Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in ...
Looking at all of its recent acquisitions, you might think Endo Pharmaceutical's (NMS:ENDP) business model echoes another firm's. One like Johnson & Johnson's (NYSE:JNJ - News). That makes sense. Endo ...
Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...
The FDA's move to request Endo Pharmaceuticals to remove its opioid drug Opana ER (oxymorphone hydrochloride) from the market is a first for the regulator. The Federal Trade Commission has sued ...
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, contact OpenSecrets: [email protected] ...
Acadia Pharmaceuticals, GlaxoSmithKline Group, Endo Pharmaceuticals, and Dendreon Pharmaceuticals. The companies lost ...
Hosted on MSN10mon
Endo Wins Court Permission to Solicit Votes on Restructuring PlanPharmaceutical company Endo International won bankruptcy court approval on Tuesday to start soliciting votes for a restructuring plan that would pay $600 million to government agencies and private ...
Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for $65 million (£47.7 million) to end their legal battle over Endo ...
Endo Pharmaceuticals, BioDelivery Sciences Present Promising Data On New Chronic Pain Management Product Endo Pharmaceuticals has Everybody Interested as M&A Target Endo Pharmaceuticals ...
Looking at all of its recent acquisitions, you might think Endo Pharmaceutical's (NMS:ENDP) business model echoes another firm's. One like Johnson & Johnson's (NYSE:JNJ - News). That makes sense.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback